Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Mouse SYN2 ELISA Kit (AC3013)
Cat.#: ASET-1602
Specifications
Description Mouse SYN2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse SYN2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.65 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 150-2400 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2153 Mouse GDF7 ELISA Kit (AC3564) Quantitative inquiry ASET-1427 Hamster Adiponectin ELISA Kit (AC2838) Quantitative inquiry ASET-1064 Mouse TSH beta ELISA Kit (AC2475) Quantitative inquiry ASET-1092 Guinea Pig PEDF ELISA Kit (AC2503) Quantitative inquiry ASET-1155 Human SOX9 ELISA Kit (AC2566) Quantitative inquiry ASET-1124 Human SOX3 ELISA Kit (AC2535) Quantitative inquiry ASET-2375 Human CDNF ELISA Kit (AC3786) Quantitative inquiry ASET-1941 Mouse TrkB ELISA Kit (AC3352) Quantitative inquiry ASET-2003 Mouse EDG8 ELISA Kit (AC3414) Quantitative inquiry ASET-1067 Human QPRT ELISA Kit (AC2478) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket